Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | AVTR Avantor, Inc. | 13G/A | 7.8% | Dec 31, 2023 | 2y |
| Clal Insurance Enterprises Holdings Ltd | ESLT Elbit Systems Ltd | 13G/A | 4.3% | Dec 31, 2023 | 2y |
| BROWN CAPITAL MANAGEMENT LLC | VCEL Vericel Corp | 13G/A | 14.29% | Dec 31, 2023 | 2y |
| OpenView Management, LLC | EXFY Expensify, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Haim Siboni | FRSX Foresight Autonomous Holdings Ltd. | 13G/A | 9.2% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | BMEA Biomea Fusion, Inc. | 13G/A | 5.9% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | SPKLF Spark I Acquisition Corp | 13G | 6% | Dec 31, 2023 | 2y |
| COHEN & STEERS, INC. | TCN Tricon Residential Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | CHAA Catcha Investment Corp | 13G | 9.23% | Dec 31, 2023 | 2y |
| Lynx1 Capital Management LP | ALPN Alpine Immune Sciences, Inc. Common Stock | 13G/A | 6.6% | Dec 31, 2023 | 2y |
| Park West Asset Management LLC | SPWR SunPower Inc. | 13G/A | 6.9% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | ZCAR Zoomcar Holdings, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Daniel A. Schreiber | LMND Lemonade, Inc. | 13G/A | 2.7% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | SMHI SEACOR Marine Holdings Inc. | 13G/A | 14.8% | Dec 31, 2023 | 2y |
| Walleye Capital LLC | GCTS GCT Semiconductor Holding, Inc. | 13G | 6.62% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | AIOT Powerfleet, Inc. | 13G | 6.42% | Dec 31, 2023 | 2y |
| LONDON CO OF VIRGINIA | NEU Newmarket Corp | 13G/A | 6.9% | Dec 31, 2023 | 2y |
| R. Kirk Huntsman | VVOS Vivos Therapeutics, Inc. | 13G/A | 4.3% | Dec 31, 2023 | 2y |
| GLENVIEW CAPITAL MANAGEMENT, LLC | BKD Brookdale Senior Living Inc. | 13G/A | 9% | Dec 31, 2023 | 2y |
| Divisadero Street Capital Management, LP | JAKK Jakks Pacific Inc | 13G/A | 0% | Dec 31, 2023 | 2y |
| Energy Income Partners, LLC | CWEN Clearway Energy, Inc. | 13G | 5.8% | Dec 31, 2023 | 2y |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | ICFI ICF International, Inc. | 13G/A | 4.96% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | TRDA Entrada Therapeutics, Inc. | 13G/A | 3.8% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | DAY Dayforce, Inc. | 13G/A | 9.6% | Dec 31, 2023 | 2y |
| HHLR ADVISORS, LTD. | ALGS Aligos Therapeutics, Inc. | 13G/A | 8.2% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | GAIA Gaia, Inc | 13G/A | 6.67% | Dec 31, 2023 | 2y |
| Portolan Capital Management, LLC | KRUS Kura Sushi USA, Inc. | 13G/A | 0.74% | Dec 31, 2023 | 2y |
| Golden Stone Capital Limited | ICG Intchains Group Ltd | 13G | 32.5% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | ELVN Enliven Therapeutics, Inc. | 13G/A | 7.2% | Dec 31, 2023 | 2y |
| TIAA-CREF Investment Management, LLC | ARCO Arcos Dorados Holdings Inc. | 13G/A | 6.74% | Dec 31, 2023 | 2y |
| NOVO HOLDINGS A/S | EVO Evotec SE | 13G/A | 8.4% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | CFIV CF Acquisition Corp. IV Class A common stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Mehana Capital LLC | SBC SBC Medical Group Holdings Inc | 13G | 67.28% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | KALA KALA BIO, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| CONTINENTAL GENERAL INSURANCE CO | ASRT Assertio Holdings, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | DG Dollar General Corp | 13G/A | 8.3% | Dec 31, 2023 | 2y |
| REDWOOD CAPITAL MANAGEMENT, LLC | GASS StealthGas Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Equinox Partners Investment Management LLC | ITRG Integra Resources Corp. | 13G/A | 10.3% | Dec 31, 2023 | 2y |
| Two Seas Capital LP | ABUS Arbutus Biopharma Corp | 13G/A | 5.4% | Dec 31, 2023 | 2y |
| EARNEST PARTNERS LLC | EFSC Enterprise Financial Services Corp | 13G/A | 5.2% | Dec 31, 2023 | 2y |
| WYNNCHURCH CAPITAL PARTNERS IV, L.P. | SWIM Latham Group, Inc. | 13G/A | 13.1% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | VMCAF Valuence Merger Corp. I | 13G | 9.9% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | HLIO Helios Technologies, Inc. | 13G | 6.4% | Dec 31, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | CMRX Chimerix, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| SCOGGIN MANAGEMENT LP | MNTS Momentus Inc. | 13G/A | 4.57% | Dec 31, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | KALV KalVista Pharmaceuticals, Inc. | 13G/A | 9.96% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | ACXP Acurx Pharmaceuticals, Inc. | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | ALGS Aligos Therapeutics, Inc. | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| Cormorant Asset Management, LP | AMAM Ambrx Biopharma, Inc. Common Stock | 13G/A | 17.78% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | OPTX Syntec Optics Holdings, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |